MajorAntiplatelet agents (low dose) / NSAIDs (analgesic dose)×NSAID, COX-2 preferential, oxicam derivative
Updated · Methodology
Mechanism
Meloxicam and aspirin are both NSAIDs. Together they damage the stomach and gut lining more, and the risk of ulcers and bleeding rises through a synergistic effect (meloxicam and aspirin 100 mg SmPCs). In a clinical study cited in the US meloxicam label (FDA), an NSAID plus aspirin caused significantly more gastrointestinal adverse reactions than the NSAID alone. Aspirin also inhibits platelet aggregation for several days after a dose (aspirin 100 mg SmPC).
Symptoms
Gum bleeding, epistaxis, bruising without trauma, black or tarry stools. Severe cases: GI bleeding.
Management
The meloxicam SmPC does not recommend combining it with aspirin at 500 mg or more per dose or 3 g or more a day, and the aspirin 100 mg SmPC advises avoiding NSAIDs with aspirin whenever possible (meloxicam and aspirin 100 mg SmPCs). The FDA does not generally recommend meloxicam with either low-dose or analgesic-dose aspirin because of bleeding risk, and notes that meloxicam is not a substitute for low-dose aspirin for cardiovascular protection (US meloxicam label). If meloxicam is still needed with low-dose aspirin, consider gastroprotection with misoprostol or a proton pump inhibitor (meloxicam SmPC). Warn the patient in advance about signs of bleeding: black stools, vomiting blood, abdominal pain, weakness, dizziness, cold sweat. If they appear, the patient stops the medicines and seeks medical care at once (aspirin 100 mg SmPC).
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Meloxicam (nº registro 66400), sección 4.5 (2023)– AEMPS, CIMA, nº registro 66400, revisión 11/2023, sección 4.5
- AEMPS: Ficha técnica: Meloxicam (Movalis 15 mg) (nº registro 61076), secciones 4.4 y 4.5 (2023)– AEMPS, CIMA, nº registro 61076, revisión 07/2023, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Ácido acetilsalicílico 100 mg (Adiro) (nº registro 62825), secciones 4.4 y 4.5 (2026)– AEMPS, CIMA, nº registro 62825, revisión 07/2026, secciones 4.4 y 4.5
- FDA: Meloxicam tablets (meloxicam) prescribing information (2025)– FDA, DailyMed setid bb83cd61-0a82-4fe0-b72e-5b715cbd656d (Cipla USA), revised 09/2025, sections 7